MedTrace Logo

Residual Neuromuscular Block in the Post-Anesthetic Unit and Postoperative Complications

NCT06386354 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 296

Last updated 2025-08-24

No results posted yet for this study

Summary

The use of neuromuscular blockers (NMB) is essential to optimize surgical conditions, ensure patient immobility during the intervention and prevent complications derived from involuntary movements. Intraoperative monitoring of neuromuscular relaxation allows the depth of neuromuscular blockade to be accurately evaluated, guaranteeing ideal conditions for the surgical team. Residual neuromuscular blockade (RNMB) is the persistence of muscle paralysis after the administration of NMB during a surgical intervention. The appearance of RNMB poses substantial challenges in the postoperative period, as it has negative repercussions for the safety and well-being of the patient.

Conditions

  • Postoperative Neuromuscular Block
  • Postoperative Complications

Interventions

DIAGNOSTIC_TEST

Train-of-four

Patients submitted to general anesthesia with neuromuscular block will be monitored at their arrival to the Post-Anesthesia Care Unit to assess the presence of residual neuromuscular block.

Sponsors & Collaborators

  • Dr. Negrin University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2025-10-30
Completion
2025-10-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06386354 on ClinicalTrials.gov